Reported about 15 hours ago
Shares of SpringWorks Therapeutics soared over 30% on news that German medical firm Merck KGaA may be acquiring the company. Reports indicate that an agreement could be reached in the coming weeks, marking the stock's highest closing price in nearly three years. Merck has expressed interest in making new acquisitions after an increase in cash reserves during the pandemic.
Source: YAHOO